✦ LIBER ✦

A Review of Safety-Related Pregnancy Data Surrounding the Oral Disease-Modifying Drugs for Multiple Sclerosis

✍ Scribed by Lu, Ellen; Wang, Bing Wei; Alwan, Sura; Synnes, Anne; Dahlgren, Leanne; Sadovnick, A. Dessa; Tremlett, Helen

Book ID: 121496250
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2013
Tongue: English
Weight: 247 KB
Volume: 28
Category: Article
ISSN: 1172-7047
DOI: 10.1007/s40263-013-0131-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Disease-modifying drugs for multiple scl

Disease-modifying drugs for multiple sclerosis in pregnancy: A systematic review

✍ Lu, E.; Wang, B. W.; Guimond, C.; Synnes, A.; Sadovnick, D.; Tremlett, H. 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 252 KB

Patient Preferences in the Choice of Dis

Patient Preferences in the Choice of Disease Modifying Drugs for Multiple Sclerosis

✍ Bergmann, A.; Lang, M.; Bischoff, C.; Schicklmaier, P.; Schiffhorst, G.; Nolting 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

The effects of long-term exposure to dis

The effects of long-term exposure to disease-modifying drugs during pregnancy in multiple sclerosis

✍ Fragoso, Yara Dadalti; Boggild, Mike; Macias-Islas, Miguel Angel; Carra, Adriana 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 333 KB

Long-Term Effects of Exposure to Disease

Long-Term Effects of Exposure to Disease-Modifying Drugs in the Offspring of Mothers with Multiple Sclerosis: A Retrospective Chart Review

✍ Fragoso, Yara D.; Adoni, Tarso; Alves-Leon, Soniza V.; Azambuja, Nério D.; Barre 📂 Article 📅 2013 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 226 KB

A health-economic evaluation of disease-

A health-economic evaluation of disease-modifying drugs for the treatment of relapsing-remitting multiple sclerosis from the German societal perspective

✍ Mark Nuijten; Thomas Mittendorf 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 156 KB

PNL5 ASSESSING ABSOLUTE REDUCTIONS IN CL

PNL5 ASSESSING ABSOLUTE REDUCTIONS IN CLINICAL EFFECT: A MODEL FOR COMPARING THE COST-EFFECTIVENESS OF DISEASE MODIFYING DRUGS (DMDS) UTILIZED IN THE TREATMENT OF MULTIPLE SCLEROSIS (MS)

✍ LD Goldberg; KS Akhras; A AL-Sabbagh; B Hall 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB